BioSpace News Archive

Deals

Skinvisible Announces Proposed Merger With Quoin Pharma

Skinvisible announced that it has entered into a non-binding term sheet regarding a proposed merger of Skinvisible with and into Quoin Pharma subject to tax, accounting, legal, regulatory, and other considerations.

November 27, 2017

·

5 min read

Business

Philips Teams With 3D Printing Industry Leaders 3D Systems and Stratasys

Royal Philips today announced agreements with 3D Systems and Stratasys, two global leaders in the 3D printing industry, to help progress patient care and improve the clinician experience.

November 27, 2017

·

6 min read

FDA

Cochlear Obtains FDA Approval for First Remote Programming Option for Cochlear Implants

This approval is the first in the cochlear implant industry and one of many steps Cochlear is taking to enable remote care for Nucleus Cochlear Implant recipients and clinicians.

November 27, 2017

·

4 min read

Drug Development

Protalix BioTherapeutics Presents Positive Results from the Phase I/II Open-Label Extension Trial for PRX-102 at the New Horizons for Fabry Disease Conference

Sixteen male and female adult patients were enrolled in the phase I/II clinical trial across three dosing cohorts (0.2 mg/kg, 1mg/kg and 2mg/kg) and received intravenous infusions of PRX-102 every two weeks.

November 27, 2017

·

7 min read

Policy

Quidel Confident in Legal Strength and Validity of Supply Agreement With Beckman Coulter to Sell BNP Assay Assets

Quidel views Beckman’s claims as meritless, and in opposition to Beckman’s long-standing strategy of honoring the Supply Agreement with its previous partners.

November 27, 2017

·

4 min read

Drug Development

aTyr Pharma Doses First Subjects in Phase I Trial of iMod.Fc (ATYR1923)

This first-in-human, randomized, double-blind, placebo-controlled study is designed to investigate the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of intravenous iMod.Fc in healthy volunteers.

November 27, 2017

·

6 min read

IBBL Participates in €34 Million EU Project on Liver Disease

he €34 million project is co-ordinated by Newcastle University, working closely with the lead EFPIA partner, Pfizer Ltd.

November 27, 2017

·

3 min read

Policy

Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST for Prophylaxis of Hereditary Angioedema Attacks

The submission includes data from two completed trials of RUCONEST for the prophylaxis of HAE attacks: a randomized, double-blind, placebo-controlled trial and an open-label study.

November 27, 2017

·

7 min read

European Patent Office Grants to ASIT Biotech a Second Patent Related to the Active Ingredients Used in the ASIT+ Allergy Immunotherapy Product Candidates

The grant will be effective from November 29, 2017 until June 15, 2032 with a possible extension of 5 years via a supplementary protection certificate.

November 27, 2017

·

5 min read

Business

GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 4 December, 2017 - Nov. 27, 2017

GW will also host a conference call the same day at 7:30 a.m. EST. Conference call information will be provided in the financial results press release.

November 27, 2017

·

1 min read